By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

bioMerieux, Inc. 

100 Rodolphe Street

Durham  North Carolina  27712  U.S.A.
Phone: 800-682-2666 Fax: n/a


SEARCH JOBS

A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors. In 2015, revenues reached 1,965 million with 90% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

YEAR FOUNDED:

1963

LEADERSHIP:

CEO: Stefan Willemsen




Key Statistics


Email:
Ownership: Private

Web Site: bioMerieux
Employees:
Symbol: 
 



Industry
Diagnostics


Collaborations

Gen-Probe Incorporated (Acquired by Hologic)  In September 2004, Gen-Probe entered into non-exclusive licensing agreements with bioMérieux and its affiliates that provide bioMérieux options to access our ribosomal RNA technologies to develop diagnostic products for certain disease targets.





Company News
bioMerieux Warns About Potential Inaccurate Test Results When Using NucliSENS easyMAG Magnetic Silica 8/17/2016 7:22:18 AM
bioMerieux Submits 510(K) Application To The bioMerieux For BacT/ALERT VIRTUO Next Generation Automated Blood Culture System 8/3/2016 6:36:24 AM
Sepsis Alliance And bioMerieux, Inc. Partner For Sepsis Awareness And Prevention 4/26/2016 8:44:24 AM
bioMerieux, Inc. And Illumina (ILMN) Announce The Launch Of bioMérieux Episeq, A Revolutionary Next-Generation Sequencing Service For Epidemiological Monitoring Of Bacterial Infections 12/15/2015 11:57:43 AM
LBT Signs Agreement With bioMerieux, Inc. For Previ Isola Automated Plate-Streaking Instrument 8/27/2015 9:48:09 AM
10 Biotech Firms Rapidly Expanding in North Carolina 7/21/2015 5:01:57 AM
bioMerieux, Inc.’s VITEK® MS System Nominated For Prestigious 2014 U.S. Prix Galien Award 10/14/2014 3:03:06 PM
bioMerieux, Inc. Joins With The Rory Staunton Foundation To Host The First National Forum On Sepsis 9/15/2014 10:24:12 AM
ATCC and bioMerieux, Inc. Collaborate To Deliver Accurate Identification Of Industrial Microorganisms 8/22/2014 10:45:57 AM
bioMerieux, Inc.'s THxID®-BRAF Test For Detection Of 2 BRAF Mutations V600E And V600K In Late-Stage Metastatic Melanoma Adopted By Clarient, Inc., A GE Healthcare Company 1/29/2014 10:49:42 AM
123456789
//-->